Brief: Imricor Medical Systems Says Northstar 3D Mapping System Got IDE Approval From US FDA
March 26 (Reuters) - Imricor Medical Systems Inc
IMR.AX :
* NORTHSTAR 3D MAPPING SYSTEM RECEIVES IDE APPROVAL FROM US
FDA
Further company coverage: IMR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion